Published in Drug Week, October 8th, 2004
In light of the liver toxicity seen with the widely prescribed cholesterol lowering drugs called statins (e.g., Lipitor, Zorcor, Mevacor), it is important to note that patients undergoing treatment with Multikine showed no liver toxicity while achieving reduction in total cholesterol levels.
Most of the patients were treated with Multikine for 2 or 3 weeks, but some of them were treated for up to 24 weeks.
A meta-analysis of the pooled...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.